WINDTREE THERAPEUTICS INC /DE/ (WINT): debt financing — Windtree raises $250K via secured notes, licenses Phexxi supply rights, regains Nasdaq compliance

WINDTREE THERAPEUTICS INC /DE/

Issued $312,500 principal in senior secured notes at 10% interest, due March 2026, with 20% OID; net proceeds $250,000.
Entered license and supply agreement with Evofem to manufacture and supply Phexxi outside the U.S. for an initial three-year term.
Regained compliance with Nasdaq minimum bid price rule (closing bid >$1.00 since Feb 21, 2025); subject to panel monitor until March 20, 2026.
Notes secured by first-priority lien on all assets; mandatory redemption of 30% of equity line proceeds if equity line is used.

item 1.01 item 2.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ incurred senior notes of aggregate principal amount of $156,250 with an institutional investor at 10% per annum maturing March 18, 2026.

Instrument: senior notes
Principal: aggregate principal amount of $156,250
Counterparty: an institutional investor
Rate: 10% per annum
Maturity: March 18, 2026
Event: incurrence

Exact text from the filing

the Company agreed to issue and sell to (i) an institutional investor an aggregate principal amount of $156,250 in senior secured notes due in 2026

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ incurred senior notes of aggregate principal amount of $156,250 with an additional institutional investor at 10% per annum maturing March 18, 2026.

Instrument: senior notes
Principal: aggregate principal amount of $156,250
Counterparty: an additional institutional investor
Rate: 10% per annum
Maturity: March 18, 2026
Event: incurrence

Exact text from the filing

(ii) an additional institutional investor an aggregate principal amount of $156,250 in senior secured notes due in 2026

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-25-008981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.